
<html><head></head><body><div><span data-mailaddress="clementlawyer@gmail.com" data-contactname="James Clement" class="clickable"><span title="clementlawyer@gmail.com">James Clement</span><span class="detail"> <clementlawyer@gmail.com></span></span> , 9/12/2014 9:37 PM:<br><blockquote class="mori" style="margin:0 0 0 .8ex;border-left:2px blue solid;padding-left:1ex;"><div class="mcntgmail_extra"><div class="mcntgmail_quote"><div>Goldman and Nedergaard's experiments are primarily concerned with finding ways to remyelinate damaged brains, but they both realize that if used in "normal" people, would likely lead to enhanced intelligence. Of course there's no easy funding for this, at least at this time.</div></div></div></blockquote></div><div><br></div>How is that supposed to work? I can imagine that a different glial architecture in a mouse has some effect, but in humans we would just get the same glial architecture. <br><div><blockquote class="mori" style="margin:0 0 0 .8ex;border-left:2px blue solid;padding-left:1ex;"><div class="mcntgmail_extra"><div class="mcntgmail_quote"><div></div></div></div></blockquote></div><div><br></div><br><br>Anders Sandberg, Future of Humanity Institute Philosophy Faculty of Oxford University</body></html>